Ritlecitinib Capsule
Substitutes & Crosswalk NDC 53869-0334

2 similar products from 2 manufacturers · Compare Brand and Generic Alternatives & Therapeutic Equivalents

Product
Package
Similar

Brand and Generic Alternatives

The similar products listed below help you identify alternative medications based on regulatory status, active ingredients, and administration routes. Identify therapeutic equivalents and alternative medications for Ritlecitinib (NDC 53869-0334). This cross-referenced list provides clinically relevant matches based on the following criteria:

Generic Bioequivalence: Products sharing the generic name: Ritlecitinib.
Administration Consistency: Same Route () and Dosage Form (capsule).
Brand Alternatives: Different proprietary names for the same chemical entity.

This clinical crossover tool is designed for healthcare professionals, pharmacists, and patients to safely compare substitute products and manage medication availability.

Search related products

Showing 2 similar products

Pfizer Laboratories Div Pfizer Inc

Human Prescription Drug

Litfulo
NDC 0069-0334

Generic Name: Ritlecitinib
Dosage Form: Capsule
Route: Oral

Active Listing

U.S. Pharmaceuticals

Human Prescription Drug

Litfulo
NDC 63539-334

Generic Name: Ritlecitinib
Dosage Form: Capsule
Route: Oral

Active Listing

Previous Product 53869-0131

Next Product 53869-0893

Page Last Updated: October 09, 2026
About Us | What is NDC? | Contact Us
Terms of Service | Privacy
NDC List 2026 - The complete repository of National Drug Codes Information

DISCLAIMER:
All contents of this website are provided on an "as is" and "as available" basis without warranty of any kind. While we strive to ensure that the information presented is accurate, up-to-date, and complete, we cannot guarantee or warrant its absolute correctness or timeliness. The contents of the National Drug Codes List website are provided for educational purposes only and are not intended in any way as medical advice, medical diagnosis, or treatment. Reliance on any information provided by the National Drug Codes List website or other visitors to this website is solely at your own risk. We do not warrant that the information on this site will meet your health-related requirements or that it is complete, timely, or suitable for your personal or professional circumstances.
By accessing or using this website, you agree to be bound by these Terms of Service. If you do not agree with any part of these terms, please do not use this site. We reserve the right to update or modify this Disclaimer or our Terms of Service at any time without prior notice. Your continued use of this site following any such changes signifies your acceptance of the revised terms.
This site is not affiliated, endorsed, or administered by the Food and Drug Administration (FDA). Many Over-the-Counter drugs are not reviewed by the FDA but may be marketed to the public if the product complies with applicable rules and regulations. The information on this website is intended for healthcare providers and consumers in the United States. The absence of a warning or notice for a given drug or drug combination does not indicate that the drug or drug combination is safe, appropriate, or effective for any given patient. If you have questions or concerns about the substances you are taking, please consult your healthcare provider.
If you think you may have a medical emergency, call your doctor or dial 911 immediately.

Do not share my Personal Information.

Brand and Generic Alternatives

Pfizer Laboratories Div Pfizer Inc

Litfulo NDC 0069-0334

U.S. Pharmaceuticals

Litfulo NDC 63539-334

Litfulo
NDC 0069-0334

Litfulo
NDC 63539-334